Immunotec Inc. is a Canadian life sciences and direct-selling company specializing in immunonutrition products, with a particular focus on whey protein-derived glutathione precursors and immune support supplementation. Founded in 1996 by immunologist Dr. Gustavo Bounous and his research partner John Molson in Vaudreuil-Dorion, Quebec, Canada, Immunotec grew directly from Dr. Bounous's decades of clinical research at McGill University and the Montreal General Hospital Research Institute, where he published foundational studies on the role of dietary whey protein in supporting cellular glutathione synthesis and immune function. The company's flagship product, Immunocal, was developed directly from this clinical research and has achieved the unusual distinction of being listed as a natural health product with recognized clinical evidence by Health Canada — making it one of the few MLM-distributed products to carry a government-recognized health claim. Immunotec operates in North America, Latin America, and selected European markets through approximately 25,000 active Consultants.
Glutathione is the most abundant intracellular antioxidant in the human body — a tripeptide (cysteine-glycine-glutamate) that serves as the cell's master defense molecule, neutralizing free radicals, supporting immune cell function, and participating in detoxification processes. The body's ability to synthesize adequate glutathione depends critically on the availability of cysteine — the rate-limiting amino acid in glutathione synthesis. Dr. Bounous's research identified that the cysteine in most dietary proteins is destroyed by heat and food processing, and that a proprietary undenatured whey protein isolate — preserved through a patented gentle processing technology that maintains the natural cystine disulfide bonds — could deliver bioavailable cysteine precursors to support glutathione synthesis more effectively than conventional supplements. Immunocal is this undenatured whey protein isolate, and its glutathione-enhancing properties are supported by published clinical studies in peer-reviewed journals including the Journal of Nutritional Science and Vitaminology and Nutrition and Cancer.
Immunocal's listing as a Natural Health Product by Health Canada with permitted claims for cysteine delivery and support of glutathione synthesis represents rare regulatory validation for an MLM-distributed nutritional product. The product has also appeared in the Physicians' Desk Reference (PDR) — a prescriber reference used by medical professionals — reflecting the medical community's awareness of the clinical research behind the product. This regulatory and medical credibility distinguishes Immunotec from the vast majority of supplement-focused MLM companies.
PLAN TYPE: Unilevel
HOW IT WORKS:
Immunotec Inc operates a Unilevel compensation structure where independent distributors earn income through a combination of retail product sales and team-building commissions. New distributors begin by purchasing products at wholesale price and selling to retail customers, earning the margin difference. As personal and group sales volume accumulate, distributors advance through rank levels that unlock progressively higher commission rates and bonus pools.
KEY INCOME STREAMS:
Retail Profit, Team Commission, Leadership Bonus, Health Coach Incentive
QUALIFICATION REQUIREMENTS:
Most commission-earning tiers require maintaining a minimum monthly personal volume (PV) or autoship order. Leadership ranks typically require both a personal volume threshold and a minimum number of active, qualifying downline members forming separate business legs. Rank advancement is based on the combined monthly volume of the entire personal organization.
INCOME DISCLOSURE:
As with all MLM compensation plans, actual earnings vary significantly based on individual sales activity, team development, market conditions, and time invested. The majority of active distributors earn supplemental income; significant full-time income is limited to a small percentage of the distributor base. Prospective participants should review the company's official Income Disclosure Statement before joining.
